Clinical Trial Results:
A randomized, open-label phase II study
evaluating the efficacy and safety of FOLFOX-4
plus cetuximab versus UFOX plus cetuximab as
first-line therapy in subjects with metastatic
colorectal cancer
Summary
|
|
EudraCT number |
2006-000685-36 |
Trial protocol |
AT FR BE GR DE IT |
Global completion date |
15 May 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Jun 2016
|
First version publication date |
24 Jun 2016
|
Other versions |
|
Summary report(s) |
2006-000685-36_Ct.gov results |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.